You are here

Health

Vaccines: Only One Harm From mRNA COVID Vaccines, Report Determines

Independent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and myocarditis, and also determined that, more broadly, intramuscular shots can cause a series of shoulder injuries.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

US respiratory virus activity declines, with few hot spots except North Dakota --CDC

Activity from the three main respiratory viruses continues to decline in the United States, with one of the main flu markers—outpatient visits for flulike illness—now below the national baseline for the first time since October, the Centers for Disease Control and Prevention (CDC) said today in its latest updates for flu, COVID, and respiratory syncytial virus (RSV).

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Covid vaccines not linked to fatal heart problems in young people --CDC study

...

the analysis shows that the risk of sudden death in young adults after being vaccinated is significantly lower than the risk of sudden cardiac death from all causes — about 1 in 500,000 per year, compared to 1 in 100,000 per year, according to his estimates.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New poll describes partisan divide over COVID vaccines

While most people believe COVID-19 vaccines are safe and their side effects are now clear, a new HarrisX poll conducted for the Deseret News finds a big partisan difference in how people view COVID-19 vaccine safety and effectiveness.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Characteristics of family practice doctors who see largest share of unvaccinated patients --Canadian study

A study today in CMAJ describes the characteristics of family practice physicians who see the largest share of patients unvaccinated against COVID-19, and reveals that the largest percentage practice in marginalized, lower-income neighborhoods. 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Health
howdy folks